Dr. Wolfgang Rehmann

Wolfgang is one of the leading experts on pharmaceutical law and medical device law in Germany. With his many years of industry knowledge and international experience, he represents small and medium-sized companies from the pharmaceutical and medical device industries, as well as global players.

In the Life Sciences team of Taylor Wessing, Wolfgang develops solutions for complex, strategic challenges facing this sector. In addition, he represents his clients' interests before authorities and in court, including in European court proceedings in Luxembourg. Wolfgang is also a lecturer at the University of Münster and at the University of Marburg.

显示完整简历隐藏完整简历

职业发展

Since 1987	Partner, Taylor Wessing
1983 – 1987	Associate, Zimmermann Hohelohe Sommer Rojahn
1982 – 1983	In-house Counsel, Fraunhofer Gesellschaft

教育

1983	Admitted as a lawyer, Munich
1983	Doctoral degree, Dr. iur. utr., Ludwig-Maximilians-Universität of Würzburg
1982	Second state examination, Bayern

1979

First state examination, Würzburg

更多显示更少

Publications

Kommentar zur Verordnung über Medizinprodukte; Co-Author: Dr. Susanne A. Wagner; Beck Verlag; 2023

AMG Kommentar Beck Verlag

MPG Kommentar co-author Beck Verlag

Arzthaftungsprozess, Luchterhand co-author

Arzneimittel und Recht, regular publications

PharmaRecht, regular publications

Medzinprodukte Journal, regular publications

Medizinproduktrecht, regular publications

会员资格和附属关系

GRUR
LIDC

语言

English

French

专长

执业领域和服务团队专利与创新生命科学监管咨询法国德国团队

行业酒店与休闲生物技术化妆品、食品营养与补品医疗器械制药数字医疗

Experience

Pharmaceutical portfolio divestments across 24 EU jurisdictions

Teva Pharmaceuticals Europe BV on its divestments of portfolios of generic pharmaceutical products (approximately 260 medicinal products) in 24 EU jurisdictions to multiple purchasers, in addition to advising Teva on the divestment of certain parts of its business. The divestments were a condition enforced by the European Commission to approve Teva's USD40.5 billion acquisition of Allergan plc’s global generics and have been run as a competitive auction process, resulting in five asset sales.

Evelyne Friedel

Dr. Wolfgang Rehmann

Radovan Pala, Ph.D., LL.M.

查看整个团队隐藏整个团队

Provision of pan-European pharma and patent advice

A leading international healthcare company on provision of European-wide advice across a variety of legal areas including pharmaceutical law and patents.

Dr. Wim Maas

Dr. Wolfgang Rehmann

奖励

Chambers Europe 2024	Ranked lawyer for Life Sciences
JUVE Handbook 2023/2024	Frequently recommended: pharmaceuticals and medical products
JUVE Awards 2023	Law firm of the year for IP Law
Who's Who Legal 2023	Thought Leaders - Germany - Life Sciences 2023
The Best Lawyers™ in Germany 2023	Leading individual: Health Care Law
The Best Lawyers™ in Germany 2023	Leading individual: Pharmaceuticals Law

The Best Lawyers™ in Germany 2023	Leading individual: Biotechnology Law and Life Sciences Practice
Who's Who Legal 2023	National Leader - Germany - Life Sciences 2023
Chambers and Partners 2023	Ranked with Chambers and Partners for Life Sciences (Germany)
JUVE Handbook 2022/2023	"expert in the field of medical device law, always available, reliable answers and practical solutions", "competent, fast, good network of correspondence lawyers", client
The Best Lawyers™ in Germany 2017- 2022	Leading individual: Pharmaceutical law
The Best Lawyers™ in Germany 2021, 2022	Leading individual: Biotechnology law
Who's Who Legal 2022	Global Leader - Regulatory
Who's Who Legal 2022	Thought Leaders - Germany - Life Sciences 2022
The Best Lawyers™ in Germany 2017, 2018, 2019, 2020, 2021, 2022	Leading individual: Health Law
JUVE Handbook 2020/2021	"Proven expert in pharmaceutical law, very satisfied", client
JUVE Handbook 2020/2021	Frequently recommended for pharmaceuticals and medical products
The Best Lawyers™ in Germany 2020	Lawyer of the year 2020: Health law
Chambers Europe 2020	Leading individual - Life Sciences - Germany: The "very strong" Wolfgang Rehmann advises clients on the regulatory aspects of transactions, as well as on compliance issues and clinical trial matters.
JUVE Handbook 2019/2020	"Grandseigneur of pharmaceutical law", competitor

更多显示更少

与我会面：

查看所有活动